TVTX Travere Therapeutics Inc

21.08

-0.02 (-0.09%)

Pre Market

Last Updated: 09:37:30

Delayed by 15 minutes

Share Name	Share Symbol	Market	Type
Travere Therapeutics Inc	NASDAQ:TVTX	NASDAQ	Common Stock

	Price Change	% Change	Share Price	Bid Price	Offer Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	-0.02	-0.09%	21.08	18.00	21.50				100	09:37:30

Form 144 - Report of proposed sale of securities

04/02/2025 1:46am

Edgar (US Regulatory)

="/Images/box-unchecked.jpg" alt="Checkbox not checked">519201/31/2025Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller

Title of Securities Sold

Date of Sale

Amount of Securities Sold

Gross Proceeds

Christopher Cline
3611 Valley Centre Drive
Suite 300
San Diego � CA � 92130

Common

01/22/2025

865

16383.87

144: Remarks and Signature

Remarks

Represents the number of shares required to be sold by the Reporting Person to cover the tax withholding obligation in connection with the settlement of vested restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the Reporting Person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the Reporting Person.

Date of Notice

02/03/2025

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ Elizabeth E. Reed as attorney-in-fact for Christopher Cline